The Problem of NBOMe

Synopsis
The NBOMe-type hallucinogens first appeared in the illicit drug market in 2010. Since that time, NBOMe-type hallucinogens have been responsible for a number of hospitalisations and deaths in Australia and globally. NBOMe-type hallucinogens have appeared as a powder, liquid, tablet or on blotter, in many cases being sold as "LSD" or "Ecstasy." There have been a number of mass-overdoses of NBOMe-type hallucinogens, which has created challenges for festival organisers and emergency services. This presentation will provide an overview of the emergence of NBOMe-type hallucinogens in Australia, provide a number of case studies of adverse reactions associated with NBOMe, and discuss the implications in terms harm reduction and crowd care services for music festivals.

Bio
CAMERON FRANCIS is a social worker who specialises in alcohol and other drug treatment. Cameron has worked in a range of capacities in the alcohol and another drug sector, including outreach at music festivals, needle and syringe program work, and as an individual counsellor for people experiencing alcohol and other drug problems.

References​
Byard RW. Cox M. Stockham P. 2016. "Blunt Craniofacial Trauma as a Manifestation of Excited Delirium Caused by New Psychoactive Substances."J Forensic Sci. 2016 Nov;61(6):1546-1548
Braden, M.R. 2007. "Towards a biophysical understanding of hallucinogen action" PhD Thesis. Purdue University, [ Ссылка ]

Heim, R. 2004. "Synthese und Pharmakologie potenter 5-HT2A-Rezeptoragonisten mit N-2 -Methoxybenzyl-Partialstruktur" Dissertation. Free University of Berlin. [ Ссылка ]

HalberstadtA.L. (2017) “Pharmacology and Toxicology of N-Benzylphenethylamine(“NBOMe”) Hallucinogens” In: Baumann M., GlennonR., Wiley J. (eds) Neuropharmacology of New Psychoactive Substances (NPS). Current Topics in Behavioral Neurosciences, vol32.

Suzuki, J. M.D., Dekker, M.A., Valenti, E.S., Fabiola, A.A.C., Correa, A.M., Poklis, J.L., Poklis, A. (2015) “Toxicities Associated With NBOMeIngestion—A Novel Class of Potent Hallucinogens: A Review of the Literature” in Psychosomatics 2015 56:2, March/April 2015 , pp129-139

Hill, S., Doris, T., Gurung, S.,Katebe, S., Lomas, A., Dunn, M., Blain, P., Thomas, S. (2013) “Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: Case series in Clinical ToxicologyJuly 2013, Vol 51, No. 6, pp487-492

Support
We're immensely grateful for your support of our botanical initiative. Entheogenesis Australis (EGA) pronominally a volunteer-run charitable, educational organisation that is in however in need of economic support. EGA is a registered charity, If your able we urge you to consider supporting our work via our web page- [ Ссылка ]

свернуть